In vitro and in vivo effects of doxycycline on Toxoplasma gondii
about
sameAs
Clinically Available Medicines Demonstrating Anti-Toxoplasma ActivityActivity of epiroprim (Ro 11-8958), a dihydrofolate reductase inhibitor, alone and in combination with dapsone against Toxoplasma gondiiModulation of myosin A expression by a newly established tetracycline repressor-based inducible system in Toxoplasma gondii.Inhibition of cytoplasmic and organellar protein synthesis in Toxoplasma gondii. Implications for the target of macrolide antibiotics.Drug repurposing screen reveals FDA-approved inhibitors of human HMG-CoA reductase and isoprenoid synthesis that block Cryptosporidium parvum growthToxoplasma gondii: susceptibility and development of resistance to anticoccidial drugs in vitro.The engineered Salmonella typhimurium inhibits tumorigenesis in advanced glioma.Engineering of bacteria for the visualization of targeted delivery of a cytolytic anticancer agent.rRNA Binding Sites and the Molecular Mechanism of Action of the Tetracyclines.TETX: a novel nuclear selection marker for Chlamydomonas reinhardtii transformation.The potential role of azithromycin in the treatment of prophylaxis of toxoplasmosis.Doxycycline and pyrimethamine for toxoplasmic encephalitis.Some pharmacokinetic parameters of doxycycline in east African goats after intramuscular administration of a long-acting formulation.Evaluation of Current and Emerging Antimalarial Medicines for Inhibition of Toxoplasma gondii Growth in Vitro
P2860
Q26782581-4D8F1871-B6BF-41E5-A12A-D30C5D1BD494Q28369142-8498FA6E-F560-486C-BBDD-8E8C82B71F5EQ33988702-FBB534F4-ACBB-4EEE-A9D2-E94641F6B2BBQ34196036-43BCCB63-30E6-41A2-B36D-39F0CCE62F18Q34574121-ECCBCD05-D6A5-40D7-9DF4-97BC2D346152Q35899924-B7721F1B-2563-46AB-94C3-DA43EC149AD2Q36116601-A7AEC45B-F13E-407E-8C73-7B94C20CD910Q37316867-FD8BEAC3-12D8-4105-881E-86F58506D224Q38849606-278A1A2D-A351-4F1F-A575-47F3C0FB2222Q39900565-C61C3698-C7D3-4C54-A039-40B5E7BF691AQ41000192-DF167AE3-D1A7-4EC7-9903-6FF85D1F27BAQ48354889-BD46A8AF-710D-468D-9916-FAB65D1EA5D9Q54016786-CA4A87D3-D775-4D21-9C7E-F1C611DA2E37Q56344152-64637991-060E-48BD-B61F-50341EF92608
P2860
In vitro and in vivo effects of doxycycline on Toxoplasma gondii
description
1990 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1990
@ast
im Mai 1990 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: May 1990)
@en
vedecký článok (publikovaný 1990-05)
@sk
vědecký článek publikovaný v roce 1990
@cs
wetenschappelijk artikel (gepubliceerd in 1990-05)
@nl
наукова стаття, опублікована в травні 1990
@uk
научни чланак (објављен 1990-05)
@sr
name
In vitro and in vivo effects of doxycycline on Toxoplasma gondii
@ast
In vitro and in vivo effects of doxycycline on Toxoplasma gondii
@en
In vitro and in vivo effects of doxycycline on Toxoplasma gondii
@nl
type
label
In vitro and in vivo effects of doxycycline on Toxoplasma gondii
@ast
In vitro and in vivo effects of doxycycline on Toxoplasma gondii
@en
In vitro and in vivo effects of doxycycline on Toxoplasma gondii
@nl
prefLabel
In vitro and in vivo effects of doxycycline on Toxoplasma gondii
@ast
In vitro and in vivo effects of doxycycline on Toxoplasma gondii
@en
In vitro and in vivo effects of doxycycline on Toxoplasma gondii
@nl
P2093
P2860
P356
P1476
In vitro and in vivo effects of doxycycline on Toxoplasma gondii
@en
P2093
P2860
P304
P356
10.1128/AAC.34.5.775
P407
P577
1990-05-01T00:00:00Z